Abstract: Disclosed herein, in certain embodiments, are peptides for use in inhibiting the interactions of PF4 and RANTES. Further disclosed herein, are methods for treating an inflammatory disease, disorder, condition, or symptom. In some embodiments, the method comprises co-administering an agent that inhibits the interactions of PF4 and RANTES and a second active agent.
Type:
Application
Filed:
July 15, 2013
Publication date:
January 2, 2014
Applicant:
Carolus Therapeutics, Inc.
Inventors:
Joshua Robert SCHULTZ, Benedikt VOLLRATH, Court TURNER
Abstract: Disclosed herein, in certain embodiments, is a method for treating a cardiovascular disorder. In some embodiments, the method comprises co-administering an inhibitor of inflammation and an agent used to treat a cardiovascular disorder.
Type:
Application
Filed:
November 12, 2009
Publication date:
July 22, 2010
Applicant:
CAROLUS THERAPEUTICS, INC.
Inventors:
Joshua Robert Schultz, Benedikt Vollrath, Court Turner
Abstract: Disclosed herein, in certain embodiments, are peptides for use in inhibiting the interactions of PF4 and RANTES. Further disclosed herein, are methods for treating an inflammatory disease, disorder, condition, or symptom. In some embodiments, the method comprises co-administering an agent that inhibits the interactions of PF4 and RANTES and a second active agent.
Type:
Application
Filed:
October 6, 2009
Publication date:
April 15, 2010
Applicant:
CAROLUS THERAPEUTICS, INC.
Inventors:
Joshua Robert Schultz, Benedikt Vollrath, Court Turner